Columbia Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$584K Sell
8,467
-38,755
-82% -$2.62M 0.64% 77
2014
Q3
$3.06M Buy
47,222
+8,892
+23% +$563K 4.11% 7
2014
Q2
$2.38M Sell
38,330
-273
-0.7% -$16.3K 1.88% 18
2014
Q1
$2.22M Buy
38,603
+5,151
+15% +$287K 1.59% 23
2013
Q4
$1.71M Buy
33,452
+325
+1% +$16.3K 1.51% 35
2013
Q3
$1.67M Buy
33,127
+9,873
+42% +$517K 1.5% 32
2013
Q2
$1.14M Buy
+23,254
New +$1.27M 1.18% 39

Other funds holding LLY

Columbia Capital's LLY Position: Q4 2014 in Review

Columbia Capital reduced its Eli Lilly (LLY) stake by 82% in Q4 2014, selling an estimated $2.62M and leaving 8,467 shares worth $584K. The position accounts for 0.64% of the portfolio, ranked #77.

Columbia Capital first reported a position in LLY in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.06M in Q3 2014. 1,130 funds tracked by Wall St. Rank hold LLY as of Q4 2014.

  • Columbia Capital held 8,467 shares of Eli Lilly worth $584K as of Q4 2014.
  • Columbia Capital sold 38,755 Eli Lilly shares in Q4 2014, an estimated $2.62M.
  • Eli Lilly made up 0.64% of Columbia Capital's portfolio in Q4 2014, its #77 holding.
  • Columbia Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 7 quarters since.
  • Columbia Capital's Eli Lilly position peaked at $3.06M in Q3 2014.
  • 1,130 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.